Evidence map›Paper›PMID 37486534›Full record

ArticleHead and neck pathology2023

HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology.

Ruta Gupta, Munita Bal, Justin A Bishop, Keith D Hunter, Kelly Magliocca, Raja R Seethala, Lester D R Thompson, Ilan Weinreb, Peter Angelos, Beth Beadle and 11 more

Abstract readLetterConsensus Statement
In one paragraph

Article in Head and neck pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ruta GuptaDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, The University of Sydney, Sydney, Australia. rutagupta@gmail.com.
Munita BalDepartment of Pathology, Tata Memorial Center, Homi Bhabha, National Institute, Mumbai, Maharashtra, India.
Justin A BishopUT Southwestern Medical Center, Houston, TX, USA.
Keith D HunterLiverpool Head and Neck Center, University of Liverpool, Liverpool, UK.
Kelly MaglioccaDepartment of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Raja R SeethalaPathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Lester D R ThompsonHead and Neck Pathology Consultations, Woodland Hills, CA, USA.
Ilan WeinrebAnatomic Pathology, University Health Network and University of Toronto Laboratory Medicine Program, Toronto, ON, Canada.
Peter AngelosEndocrine Surgery, University of Chicago, Chicago, IL, USA.
Beth BeadleRadiation Oncology, Stanford University, Palo Alto, CA, USA.
R Bryan BellEarle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.
Jonathan R ClarkHead and Neck Surgery, Chris O'Brien Lifehouse, Royal Prince Alfred Institute of Academic Surgery, The University of Sydney, Sydney, Australia.
Robert FerrisHead and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, USA.
Shao Hui HuangRadiation Oncology, Princess Margaret Cancer Center, Toronto, ON, Canada.
D Neil HayesHealth Science CenterCenter for Medical Research Memphis, University of Tennessee, Memphis, TN, USA.
Rahul LadwaMedical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Jean YangDepartment of Mathematics and Statistics, University of Sydney, Sydney, Australia.
Nicole A CiprianiDepartment of Surgical Pathology, University of Chicago, Illinois, USA.
Brenda L NelsonScripps Oral Pathology Service, San Diego, CA, USA.
Peter M SadowDepartments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
James S LewisDepartment of Pathology, Microbiology and Immunology, Department of Otolaryngology and Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

Funding

WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Greg M. Delgoffe · 2004 to 2026
$49.6M
NCI NIH HHS P50 CA097190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Head and Neck NeoplasmsLanguageHeadHumansReproducibility of Results

Identifiers

PMID37486534
PMCPMC10513968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.